INFOS !
  • NEW ADDRESS: The management team of ERN-EYE is moving! Starting from March 19, you can find us at 1 Rue Eugène Boeckel, 67000 Strasbourg.

Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Trouble using our website?
Contact us

Pr Martin Spitzer

In this page

Member info

Pr Martin Spitzer

Representative

Germany

Working Group(s): Retinal Rare Eye Diseases (WG1), Pediatric Ophthalmology Rare Diseases (WG3), Research (TWG8)

HCP Center

Since its foundation in 1889, the Medical Center Hamburg-Eppendorf (UKE) has been one of the leading clinics in Europe. Based on the interconnection...

contact

Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany

Martinistraße 52
20251 Hamburg
Germany

Clinical trials

NCT05566795 Recruiting, Active

A Phase 3, Randomized, International Multicenter Trial of DAY101 Monotherapy Versus Standard of Care Chemotherapy in Patients with Pediatric Low-Grade Glioma Harboring an Activating RAF Alteration Requiring First-Line Systemic Therapy

Interventional
See the trial
voir la fiche
NCT04435366 Completed

A Phase 3 Multicenter, Randomized, Double Masked, Sham- Controlled Clinical Trial to Assess the Safety and Efficacy of Intravitreal Administration of Zimura (Complement C5 Inhibitor) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Interventional
See the trial
voir la fiche

NCT05384249 Active, Not recruiting

A Phase 2b Pivotal Study to Evaluate the Efficacy and Safety of Izokibep in Subjects With Non-infectious, Intermediate-, Posterior- or Pan-uveitis

Interventional
See the trial
voir la fiche
NCT04939571 Recruiting, Active

European Disease Registry on Retinopathy of Prematurity (ROP)

Observational
See the trial
voir la fiche
307690

Retrospective Chart Review Study Combined with Cross-sectional Patient and Caregiver Surveys to Document and Describe the Disease-related Clinical, Individual, Sociodemographic Characteristics of Patients with X-linked Retinitis Pigmentosa (XLRP) and the Impact of XLRP on Patients and Their Caregivers

Observational
See the trial
voir la fiche
NCT04965038 Recruiting, Active

Early Reperfusion Therapy With Intravenous Alteplase for Recovery of VISION in Acute Central Retinal Artery Occlusion

Interventional
See the trial
voir la fiche
NCT04924608 Active, Not recruiting

A Phase III, Multicentre, International Study With a Parallel, Randomised, Double-blind, Placebo-controlled, 2 Arm Design to Assess the Efficacy and Safety of Selumetinib in Adult Participants With NF1 Who Have Symptomatic, Inoperable Plexiform Neurofibromas (KOMET)

Interventional
See the trial
voir la fiche
NCT04088409 Active, Not recruiting

An Open-label, Active-Controlled, Safety, and Efficacy Study of Oral Baricitinib in Patients From 2 Years to Less Than 18 Years Old With Active Juvenile Idiopathic Arthritis-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis

Interventional
See the trial
voir la fiche
NCT04663750 Recruiting, Active

Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER)

Interventional
See the trial
voir la fiche
NCT05407636 Recruiting, Active

Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD (ASCENT)

Interventional
See the trial
voir la fiche
NCT04657289 Recruiting, Active

A Study of the Efficacy, Safety, and Pharmacokinetics of A 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome)

Interventional
See the trial
voir la fiche
NCT05841914 Not yet recruiting

Multicentre Implementation and Validation of a Molecular Diagnostic for VitreoRetinal Lymphoma (DecodeVRL)

Observational
See the trial
voir la fiche